跳至主要内容
临床试验/NCT07593443
NCT07593443尚未招募不适用

Member Engagement Application for Personalized Arts-based Social Prescriptions

SocialRx Inc0 个研究点目标入组 230 人开始时间: 2026年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
230

研究概览

简要总结

The goal of this clinical trial is to learn if a personalized arts-based social prescribing program, Art Pharmacy, delivered through a mobile app (SocialRx App) can improve mental health and social connectedness in adolescents aged 15-18 with depression or anxiety enrolled in Medicaid managed care.

The main question it aims to answer is:

Compared to stable treatment, does participation in the Art Pharmacy program through the SocialRx App improve depression, anxiety, social connectedness, and loneliness? Researchers will compare participants receiving the Art Pharmacy program and digital companion to those receiving stable treatment (no change to existing care) to evaluate its effects on mental health and social connectedness.

Participants will:

Be randomly assigned to either the Art Pharmacy program delivered through the SocialRx App or a control group receiving stable treatment.

Complete online surveys at baseline and follow-up time points (e.g., 3, 6, 9, and 12 months).

If assigned to the intervention group, Art Pharmacy, participants will receive monthly arts and cultural activity recommendations, attend activities, and interact with a care navigator delivered through the SocialRx App.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
15 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Participants must meet the following criteria:
  • Aged 15-18 years enrolled in Medicaid managed care
  • Positive screen for depression and/or anxiety (e.g., PHQ-2 or GAD-2 ≥ 3)
  • Currently own and easily operate a smartphone
  • Have a valid e-mail address checked regularly
  • English fluency, and
  • Have a stable treatment regimen for at least 30 days prior to baseline with no planned treatment changes.

排除标准

  • Participants will be excluded if they:
  • Endorse current suicidal ideation at study screening, defined as a response ≥ 1 ("several days") on Item 9 of the PHQ-9A
  • Initiate a new treatment regimen or plan on initiating a new treatment regimen (i.e., medication, psychotherapy, or mind-body interventions) at the time of enrollment.

研究者

发起方
SocialRx Inc
申办方类型
Industry
责任方
Principal Investigator
主要研究者

Dawn McDaniel

Research Scientist

SocialRx Inc

相似试验